You're absolutely correct, Mr. Lee. I think that's where it takes political will to do it, at the end of the day. I've always believed that this legislation was built so it won't actually be applicable and achieve results. There is so much bias, in terms of not getting an end result, that it's stuck here.
What is happening in your particular case? You actually have the process completed to the point where people can access it if they want. Is it because there are no timelines in negotiations between generics and pharmaceuticals on the price of it? Is that the holdup? What has been the feedback at this point from your cases on why it's not going to the next level?